Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study
Weifeng Ma, Peng Chen, Xian‐Sen Huo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112847-112847
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

An Overview of the Biological Evaluation of Selected Nitrogen-Containing Heterocycle Medicinal Chemistry Compounds
Oluwakemi Ebenezer, Maryam Amra. Jordaan, Gea Carena, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8117-8117
Open Access | Times Cited: 54
Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines
Xian‐Sen Huo, Xie‐Er Jian, Jie Ouyang, et al.
European Journal of Medicinal Chemistry (2021) Vol. 220, pp. 113449-113449
Closed Access | Times Cited: 46
Design, Synthesis, and Antiproliferative Activity of Novel Indole/1,2,4-Triazole Hybrids as Tubulin Polymerization Inhibitors
Esraa Mahmoud, Dalia Abdelhamid, Anber F. Mohammed, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 275-275
Open Access
An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Haoxiang Weng, Jinlong Li, Huajian Zhu, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 73-95
Open Access | Times Cited: 12
Rational design, synthesis and biological evaluation of novel 2-(substituted amino)-[1,2,4]triazolo[1,5-a]pyrimidines as novel tubulin polymerization inhibitors
Lin Chen, Tangyang Ji, Xian‐Sen Huo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114864-114864
Closed Access | Times Cited: 21
Design and synthesis of new bis(1,2,4-triazolo[3,4-b][1,3,4]thiadiazines) and bis((quinoxalin-2-yl)phenoxy)alkanes as anti-breast cancer agents through dual PARP-1 and EGFR targets inhibition
Fatma M. Thabet, Kamal M. Dawood, Eman A. Ragab, et al.
RSC Advances (2022) Vol. 12, Iss. 36, pp. 23644-23660
Open Access | Times Cited: 18
Discovery of 6-aryl-2-(3,4,5-trimethoxyphenyl)thiazole[3,2-b][1,2,4]triazoles as potent tubulin polymerization inhibitors
Na Li, Qi Guan, Yilang Hong, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115402-115402
Closed Access | Times Cited: 11
Discovery of novel 6-p-tolyl-3-(3,4,5-trimethoxybenzyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivative as a potent tubulin inhibitor with promising in vivo antitumor activity
Tangyang Ji, Xie‐Er Jian, Lin Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115437-115437
Closed Access | Times Cited: 11
Vision on Synthetic and Medicinal Facets of 1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine Scaffold
Ranjana Aggarwal, Mona Hooda, Prince Kumar, et al.
Topics in Current Chemistry (2022) Vol. 380, Iss. 2
Open Access | Times Cited: 17
2-Methoxydiol derivatives as new tubulin and HDAC dual-targeting inhibitors, displaying antitumor and antiangiogenic response
Moran Sun, Jinling Qin, Yingying Kang, et al.
Bioorganic Chemistry (2022) Vol. 120, pp. 105625-105625
Closed Access | Times Cited: 16
Synthesis and Anti-Breast Cancer Potency of Mono- and Bis-(pyrazolyl[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine) Derivatives as EGFR/CDK-2 Target Inhibitors
Mostafa E. Salem, Esraa M. Mahrous, Eman A. Ragab, et al.
ACS Omega (2023) Vol. 8, Iss. 38, pp. 35359-35369
Open Access | Times Cited: 9
Design, synthesis and biological evaluation of indole-based [1,2,4]triazolo[4,3-a] pyridine derivatives as novel microtubule polymerization inhibitors
Cheng-Jun Wu, Jia‐Qiang Wu, Yunfei Hu, et al.
European Journal of Medicinal Chemistry (2021) Vol. 223, pp. 113629-113629
Closed Access | Times Cited: 21
Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect
Tarek S. Ibrahim, Mohamed M. Hawwas, Azizah M. Malebari, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 802-818
Open Access | Times Cited: 20
Design, synthesis, and biological evaluation of N-(pyridin-3-yl)pyrimidin-4-amine analogues as novel cyclin-dependent kinase 2 inhibitors for cancer therapy
Wenbin Zeng, Tangyang Ji, Yanting Zhang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107019-107019
Closed Access | Times Cited: 8
Synthetic Methods and Pharmacological Potentials of Triazolothiadiazines: A Review
Mohamed S. Mostafa, Ibrahim Ali M. Radini, Naglaa M. Abd El‐Rahman, et al.
Molecules (2024) Vol. 29, Iss. 6, pp. 1326-1326
Open Access | Times Cited: 2
Unveiling the anti-cancer potentiality of phthalimide-based Analogues targeting tubulin polymerization in MCF-7 cancerous Cells: Rational design, chemical Synthesis, and Biological-coupled Computational investigation
Ateyatallah Aljuhani, Mohamed S. Nafie, Nader R. Albujuq, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107827-107827
Closed Access | Times Cited: 2
Discovery and biological evaluation of 6-aryl-4-(3,4,5-trimethoxyphenyl)quinoline derivatives with promising antitumor activities as novel colchicine-binding site inhibitors
Qianqian Xu, Yuxuan Tu, Yujing Zhang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116869-116869
Closed Access | Times Cited: 2
Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization
Moran Sun, Yixin Zhang, Jinling Qin, et al.
Bioorganic Chemistry (2021) Vol. 113, pp. 104988-104988
Closed Access | Times Cited: 19
A Review on the Synthesis and Anticancer Potentials of Imidazothiazole Derivatives
Payal Kamboj, Anjali Mahore, Asif Husain, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 23, Iss. 17, pp. 1733-1759
Closed Access | Times Cited: 7
Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
Wei Liu, Youyou He, Zhongjie Guo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization
Shuyu Wang, Xu Liu, Lingwei Meng, et al.
Bioorganic & Medicinal Chemistry Letters (2021) Vol. 43, pp. 128095-128095
Closed Access | Times Cited: 13
Discovery of new indole-based 1,2,4-triazole derivatives as potent tubulin polymerization inhibitors with anticancer activity
Fang Yang, Xie‐Er Jian, Lin Chen, et al.
New Journal of Chemistry (2021) Vol. 45, Iss. 46, pp. 21869-21880
Closed Access | Times Cited: 13
Discovery of 2‐Amino‐4H‐1, 3, 4‐thiadiazine‐5(6H)‐one Derivatives and Their In Vitro Antitumor Investigation
Faten Z. Mohammed, Youstina William Rizzk, Ibrahim M. El‐Deen, et al.
ChemistrySelect (2022) Vol. 7, Iss. 7
Closed Access | Times Cited: 9
Discovery of (2-(pyrrolidin-1-yl)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone as a novel potent tubulin depolymerizing and vascular disrupting agent
Chao Tian, Meng Wang, Xueqi Shi, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114466-114466
Closed Access | Times Cited: 9
Benzothiazole‐based apoptosis inducers: A comprehensive overview and future prospective
Payal Kamboj, Anjali Mahore, Asif Husain, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 4
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top